Fonar Quick Ratio 2010-2024 | FONR
Historical quick ratio values for Fonar (FONR) over the last 10 years.
| Fonar Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2024-12-31 | $0.14B | $0.01B | 11.01 |
| 2024-09-30 | $0.14B | $0.01B | 9.45 |
| 2024-06-30 | $0.14B | $0.02B | 7.71 |
| 2024-03-31 | $0.13B | $0.02B | 9.16 |
| 2023-12-31 | $0.13B | $0.01B | 9.15 |
| 2023-09-30 | $0.13B | $0.01B | 8.88 |
| 2023-06-30 | $0.12B | $0.02B | 7.88 |
| 2023-03-31 | $0.12B | $0.01B | 8.57 |
| 2022-12-31 | $0.12B | $0.01B | 8.59 |
| 2022-09-30 | $0.12B | $0.02B | 7.84 |
| 2022-06-30 | $0.12B | $0.02B | 6.95 |
| 2022-03-31 | $0.11B | $0.01B | 7.90 |
| 2021-12-31 | $0.11B | $0.01B | 7.98 |
| 2021-09-30 | $0.11B | $0.02B | 6.62 |
| 2021-06-30 | $0.11B | $0.02B | 5.33 |
| 2021-03-31 | $0.10B | $0.02B | 5.95 |
| 2020-12-31 | $0.10B | $0.02B | 5.89 |
| 2020-09-30 | $0.10B | $0.02B | 5.22 |
| 2020-06-30 | $0.09B | $0.02B | 5.05 |
| 2020-03-31 | $0.09B | $0.02B | 6.02 |
| 2019-12-31 | $0.09B | $0.02B | 5.91 |
| 2019-09-30 | $0.09B | $0.01B | 6.13 |
| 2019-06-30 | $0.08B | $0.01B | 5.91 |
| 2019-03-31 | $0.08B | $0.01B | 6.83 |
| 2018-12-31 | $0.07B | $0.01B | 6.19 |
| 2018-09-30 | $0.07B | $0.01B | 5.85 |
| 2018-06-30 | $0.07B | $0.02B | 4.51 |
| 2018-03-31 | $0.06B | $0.01B | 4.82 |
| 2017-12-31 | $0.06B | $0.01B | 4.31 |
| 2017-09-30 | $0.05B | $0.01B | 3.92 |
| 2017-06-30 | $0.05B | $0.01B | 3.64 |
| 2017-03-31 | $0.05B | $0.01B | 3.33 |
| 2016-12-31 | $0.05B | $0.02B | 2.65 |
| 2016-09-30 | $0.05B | $0.02B | 2.45 |
| 2016-06-30 | $0.04B | $0.02B | 2.11 |
| 2016-03-31 | $0.05B | $0.02B | 2.62 |
| 2015-12-31 | $0.05B | $0.02B | 2.45 |
| 2015-09-30 | $0.05B | $0.02B | 2.26 |
| 2015-06-30 | $0.04B | $0.02B | 2.21 |
| 2015-03-31 | $0.04B | $0.02B | 2.01 |
| 2014-12-31 | $0.04B | $0.02B | 2.13 |
| 2014-09-30 | $0.04B | $0.02B | 1.96 |
| 2014-06-30 | $0.04B | $0.02B | 1.93 |
| 2014-03-31 | $0.04B | $0.02B | 1.84 |
| 2013-12-31 | $0.04B | $0.02B | 1.77 |
| 2013-09-30 | $0.04B | $0.02B | 1.74 |
| 2013-06-30 | $0.04B | $0.02B | 1.70 |
| 2013-03-31 | $0.04B | $0.02B | 1.54 |
| 2012-12-31 | $0.03B | $0.02B | 1.28 |
| 2012-09-30 | $0.03B | $0.02B | 1.18 |
| 2012-06-30 | $0.02B | $0.02B | 1.12 |
| 2012-03-31 | $0.02B | $0.02B | 1.06 |
| 2011-12-31 | $0.02B | $0.02B | 0.97 |
| 2011-09-30 | $0.02B | $0.02B | 0.89 |
| 2011-06-30 | $0.02B | $0.02B | 0.87 |
| 2011-03-31 | $0.02B | $0.02B | 0.61 |
| 2010-12-31 | $0.01B | $0.03B | 0.50 |
| 2010-09-30 | $0.01B | $0.03B | 0.51 |
| 2010-06-30 | $0.01B | $0.03B | 0.48 |
| 2010-03-31 | $0.01B | $0.03B | 0.48 |
| 2009-12-31 | $0.01B | $0.03B | 0.49 |
| 2009-09-30 | $0.02B | $0.03B | 0.53 |
| 2009-06-30 | $0.02B | $0.03B | 0.52 |
| 2009-03-31 | $0.02B | $0.03B | 0.48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.076B | $0.103B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| Agilent Technologies (A) | United States | $29.217B | 19.30 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |